comparemela.com
Home
Live Updates
EirGenixs Breast Cancer Biosimilar Receives Marketing Authorization by EC : comparemela.com
EirGenix's Breast Cancer Biosimilar Receives Marketing Authorization by EC
/PRNewswire/ -- EirGenix Inc. (6589. TT) announced today that its trastuzumab biosimilar medicine (EG12014) which their commercial partner Sandoz plans to...
Related Keywords
Russia ,
Taipei ,
T Ai Pei ,
Taiwan ,
China ,
,
Ministry Of Health ,
Eirgenix Inc ,
European Commission ,
Prnewswire Eirgenix Inc ,
National Health Insurance Administration ,
Eirgenix ,
Health Care Amp Hospitals ,
Medical Pharmaceuticals ,
Pharmaceuticals ,
International Medical Approval ,
comparemela.com © 2020. All Rights Reserved.